The end of pharma liability?

The U.S. Supreme Court heard oral argument on Wyeth v. Diane Levine today, raising questions about the limits of federal preemption.

My colleague Julia Reed Zaic raises the concern that broader federal preemption will mean the end of state tort liability for big pharmaceutical companies.

According to her analysis, the case could take away right to sue a pharma company in state court...among other things. The plaintiffs' amici included a physician's association.

Watch the Court's opinion on this one.